As of Aug 24
| +0.09 / +1.71%|
The 6 analysts offering 12-month price forecasts for Veracyte Inc have a median target of 9.50, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a +77.90% increase from the last price of 5.34.
The current consensus among 7 polled investment analysts is to Buy stock in Veracyte Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.